VR Integrated Into Multicomponent Interventions for Improving Sleep in ICU

August 13, 2025 updated by: Hsiao-Yean Chiu

Strategies Establishment for Promoting Sleep Quality and Quantity of Patients Requiring Intensive Care: Verifying the Effect of Virtual Reality Integrated Into Multicomponent Interventions

Background: The patients who are admitted to ICUs mostly experience sleep disturbance. Seeking an effective strategy and integrating it into the daily routine is of clinical importance. Therefore, we aim to examine the effects of guided virtual reality integrated into the multicomponent program (SLEEP care) on sleep quality and quantity in critically ill patients. This will be a randomized controlled trial with assessor-blinded and two-arm parallel-group design. A total of 120 critical ill adults will be randomly allocated to the SLEEP care group and eyemask groups in a 1:1 ratio (60 participants in each group).

Study Overview

Status

Completed

Detailed Description

This study is expected to enroll 120 critically ill patients. We will collect basic data on the first day of admission to the intensive care unit, including demographics and disease characteristics, pain, anxiety, and stress, sleep quality and quantity, measure 5-minute HRV, wear an actigraph watch, and connect to the on-lead EEG sensor, and attach the brain wave to monitor the brain wave and sleep cycle. Then they will be randomly assigned 1:1, dividing into SLEEP care group and eyemask group. Participants who are in the control will receive eyemask intervention and daily care in the ICU. Participants who are assigned to the SLEEP care group will receive the VR and night sleep promotion routine. The researcher will assist participants to wear a virtual reality helmet for a 30-minute program at 10 pm, and then remove the helmet and wear eye masks until 6:30 in the morning. The ICU routine care of promoting sleep is still maintained. The next morning (the second day of the ICU), the researcher will assist participants to remove EEG sensors and evaluate the RCSQ scale to understand the previous night's sleep. The above process will repeat for three days (ICU days 1 to 3) until the intervention and measurement during the intensive care unit are completed on the morning of the fourth day. In order to understand the impact of sleep on cognitive function during the stay in the intensive care units and after discharge, the PSQI, VAS of pain, anxiety, and stress (confounders), and MOCA will be evaluated in the first and sixth months after discharge.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan
        • Taipei Medical University Hospital.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 20 years and above.
  • Conscious and able to communicate with Chinese or Mandarin.
  • To stay in ICU at least 72 hrs

Exclusion Criteria:

  • The medical history of sleep disorder, cognition impairment, psychiatric disorders, seizures, visual difficulty or hearing difficulty
  • The APACHE II score over than 25
  • The participates who are delirium

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual reality combine with sleep promotion routine
Participants will receive virtual reality for 30 minutes before bedtime then will be placed on an eye mask and combine with the sleep promotion routine. The intervention duration need continues for two days or until discharge from ICU.
Participates will receive a virtual reality program 30 min before their sleep and combine with the sleep routine program for consecutive 2 nights in the ICU.
No Intervention: control group
Participants will receive eye masks during their sleep for consecutive two days or until discharge from ICU.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in subjective sleep quality from first day to 3rd day of ICU recruitment
Time Frame: The 1st to 3rd day of ICU recruitment
Subjective sleep quality in ICU is assessed by Richards-Campbell Sleep Questionnaire(RCSQ). The mean of total score is 0-100. The higher score means the better sleep quality.
The 1st to 3rd day of ICU recruitment
Change of subjective sleep quality from before ICU and admission for 30 and 180 days after ICU discharge
Time Frame: The 1st day of ICU recruitment, 30 and 180 days days after ICU discharge
sleep quality is assessed by Pittsburgh Sleep Quality. Index(PSQI). The total score is 0-21. The higher score means the worse sleep quality.
The 1st day of ICU recruitment, 30 and 180 days days after ICU discharge
Change of objective sleep from 1st day to 3rd day of ICU recruitment
Time Frame: The 1st day to 3rd day of ICU recruitment
Objective sleep quality in ICU is measured by actigraphy
The 1st day to 3rd day of ICU recruitment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of quality of life from the first day of ICU recruitment, 30 and 180 day after ICU discharge
Time Frame: The 30 and 180 days after ICU discharge
Cognitive function is assessed by MoCA. The total scales is 30. The scale is more than 26 means the patients do not have cognitive impairment.
The 30 and 180 days after ICU discharge
Delirium occurrence
Time Frame: The 1st to 3th days of ICU recruitment
Delirium is assessed by Intensive Care Delirium Screening Checklist (ICDSC) or Confusion Assessment Method for the intensive care unit (CAM-ICU)
The 1st to 3th days of ICU recruitment
Change of heart rate variability
Time Frame: The 1st and 3rd days of ICU recruitment
Heart rate variability is measured by portable ECG recorder and analyzer.
The 1st and 3rd days of ICU recruitment
Change from baseline on anxiety
Time Frame: the 1st day of ICU recruitment and up to 30 and 180 days
Anxiety is assessed by Visual Analog Scale (VAS) anxiety scoring.The scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain(score of 10) .The higher score means the very anxiety.
the 1st day of ICU recruitment and up to 30 and 180 days
Change of stress
Time Frame: The 1st day of ICU recruitment, 30 and 180 days after ICU discharge
Stress is assessed by Visual Analog Scale(VAS) stress scoring.The scale is most commonly anchored by "no stress" (score of 0) and "very stressful(score of 10) .The higher score means the very stressful.
The 1st day of ICU recruitment, 30 and 180 days after ICU discharge
Change of pain
Time Frame: The 1st day of ICU recruitment, 30 and 180 days days after ICU discharge
Pain is assessed by Visual Analog Scale(VAS) pain scoring.The scale is most commonly anchored by "no pain" (score of 0) and "very painful(score of 10) .The higher score means the very painful.
The 1st day of ICU recruitment, 30 and 180 days days after ICU discharge
Electroencephalography
Time Frame: The 1st day to 3rd day of ICU recruitment
Electroencephalography is measured by SOMNOwatch
The 1st day to 3rd day of ICU recruitment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Hsiao-Yean Chiu, Taipei Medical University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 20, 2022

Primary Completion (Actual)

March 6, 2024

Study Completion (Actual)

February 3, 2025

Study Registration Dates

First Submitted

August 25, 2022

First Submitted That Met QC Criteria

August 25, 2022

First Posted (Actual)

August 29, 2022

Study Record Updates

Last Update Posted (Actual)

August 17, 2025

Last Update Submitted That Met QC Criteria

August 13, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Quality

Clinical Trials on Virtual reality and eye mask

Subscribe